Biofrontera Inc. (BFRI) Total liabilities 2020–2025
Biofrontera Inc. (BFRI) total liabilities at each fiscal year-end, per SEC filings.
$18.1MFY2025 · since FY2020: $18.3M → $18.1M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $18.1M | +2.4% |
| FY2024 | $17.7M | -23.6% |
| FY2023 | $23.1M | -14.3% |
| FY2022 | $27.0M | -35.5% |
| FY2021 | $41.9M | +128.7% |
| FY2020 | $18.3M | — |
Years the filer does not tag total liabilities directly are shown as reported total assets − reported shareholders’ equity at the same fiscal year-end.
Source: SEC XBRL filings · For reference only · Not investment advice
More BFRI financial trends
BFRI RevenueBFRI Net incomeBFRI Net marginBFRI Gross profitBFRI Gross marginBFRI Operating incomeBFRI Operating marginBFRI Operating cash flowBFRI Free cash flowBFRI Capital expendituresBFRI Return on equityBFRI Stock buybacksBFRI Dividends paidBFRI Total assetsBFRI Shareholders’ equityBFRI overview →